Shylaja Srinivasan is an Endocrinology/Metabolic physician affiliated with University of California, San Francisco. OpenAlex indexes 102 publications with 1,566 citations (h-index 20); ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
355 Abbott St Ste 200
Salinas, CA 939014483
Telephone
831-422-3636Registry record last updated 29 May 2019.
Clinical trials
- Artificial Intelligence-based Methods to Predict Disease Progression in Youth With Type 2 Diabetes
Sponsor: University of California, San Francisco
- Precision Dosing of Metformin in Youth With T2D
Sponsor: University of California, San Francisco
- Continuous Glucose Monitoring System Feasibility in Youth With T2D
Sponsor: University of California, San Francisco
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Abbott LaboratoriesProgram year20241 payment
- Tolmar, Inc.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
2 NIH research awards on record, funded 2020–2025 per NIH RePORTER. The latest:
- Pathophysiological sub-typing of pediatric type 2 diabetes based on clinical and genetic clustering methods
University of California, San Francisco
FY2025$121,125R03DK138213 - A comprehensive approach to understanding the determinants of metformin pharmacokinetics and pharmacodynamics in youth with type 2 diabetes
University of California, San Francisco
FY2024$219,321K23DK120932 - Pathophysiological sub-typing of pediatric type 2 diabetes based on clinical and genetic clustering methods
University of California, San Francisco
FY2024$121,125R03DK138213
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Emmanuelle Waubant, MD
University of California, San Francisco
Peter Ganz, MD
University of California, San Francisco
Joel Palefsky, MD
University of California, San Francisco
Peter Hunt, MD
University of California, San Francisco
Yousef Saleh Khader
Jordan University of Science and Technology
Jens Juul Holst
University of Copenhagen
Victor Montori, MD
Mayo Clinic
Christos Mantzoros, MD
Harvard Medical School
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”